BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2016
View Archived Issues
Alpine Immune Sciences announces USD 48 million series A financing
Read More
EnBiotix signs deal with Mayo Clinic to continue development of EPP-001
Read More
Regen BioPharma identifies small molecules that activate NR2F6
Read More
Marathon Pharmaceuticals submits NDA to FDA for deflazacort in DMD
Read More
Shire signs global rights agreement with Pfizer for PF-00547659
Read More
Promising activity seen in colorectal cancer study with encorafenib, cetuximab and alpelisib
Read More
Janssen BACE inhibitor studied for Alzheimer's in asymptomatic subjects
Read More
Novartis patents complement factor D inhibitors
Read More
The Medicines Company doses first patient in phase II trial of ABP-700
Read More
PharmaMar starts trial for plitidepsin in patients with T-cell lymphoma
Read More
GlaxoSmithKline discloses CD38 inhibitors
Read More
Merck & Co. describes BACE 1/2 inhibitors
Read More
Takeda Pharmaceutical develops ACC1 inhibitors
Read More
Advanced Proteome Therapeutics annnounces partnership with Heidelberg Pharma
Read More
New ADC IMGN-632 shows promising preclinical results in AML
Read More
Phase I/II study finds encouraging survival with VAL-083 in recurrent glioblastoma
Read More
[18F]FTP2, a novel PET probe to detect gefitinib-resistant tumors
Read More
PRX-003: first-in-human data
Read More
Sirukumab: data from SIRROUND-D
Read More
twoXAR completes preclinical studies to evaluate rheumatoid arthritis candidates
Read More
Topline results from phase II study of duvelisib in refractory indolent NHL
Read More
Mesoblast regains rights to mesenchymal precursor cell technology platform
Read More
Vicore completes first-in-human study of C-21
Read More